MedPath

Evaluation of the Performance of a hsRDT Versus cRDT in Reactive Case Detection of Malaria Infections

Not Applicable
Conditions
Malaria,Falciparum
Malaria Diagnosis
Interventions
Diagnostic Test: hsRDT
Registration Number
NCT03511443
Lead Sponsor
University Research Co, LLC
Brief Summary

A systematic review assessing the role, appropriateness and benefits of the active case detection strategy, both proactive and reactive, in low malaria transmission settings. A common indication is that more studies should be carried out to optimize the ACD strategy to the local context, or to provide evidence for the adoption of improved methods. One possible improved method is the use of more accurate diagnostic tools, such as the hsRDT proposed in this study, with an increased capacity to detect lower levels of parasitemia. It can provide a timely and relevant contribution for their development of national Standard Operating Procedures for a screening tool in the reactive case detection strategy.

Detailed Description

The study is conducted in the areas under Sakhanmaw Rural Health Center, Ann Township in Southern Rakhine State, Myanmar.

General objective was to evaluate the performance of the new highly-sensitive rapid diagnostic test (RDT) developed by SD Bioline versus conventional RDT, compared with PCR as the gold standard, in reactive case detection of malaria infections in Rakhine State, Myanmar.

Specific objectives

* To evaluate the prevalence of malaria identified by the new hsRDT in comparison with that by cRDT and PCR

* To assess the diagnostic performance characteristics of hsRDT versus cRDT, using PCR as gold standard, in the detection of P.falciparum infections

* To evaluate correlation of detection capability between cRDT and hsRDT

* To identify risk factors associated with malaria infection, including but not limited to, socio-demographic factors and travel history related with malaria index cases

This is a prospective community-based single-center reactive case detection (RCD) study to assess the performance of hsRDT versus cRDT in identifying individuals with malaria infection ("Secondary case") in a population living and/or working in a close physical proximity to an "index case." All cases parasitologically confirmed by conventional RDT will be promptly notified to the study team and interviewed with a standardized case investigation form at their home, possibly within 3 days. All members of the primary case household and those of the nearest 10 households, aged 5 years and above, will be invited to participate in the study. A blood spot will be collected for subsequent PCR analysis. At least 50 index cases are targeted for investigation and reactive case detection and an estimated number of 1,980 persons will be involved in the study.

It is expected that this study will be an important input for the national malaria control program in Myanmar as they develop the strategies to conduct reactive case detection.

A suitable statistical software, e.g. STATA will be used to analyze the data resulting from the participant interviews and 3 parasitological tests. Logistic regression models will be developed to examine factors significantly associated with malaria infections.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1980
Inclusion Criteria
  • Age at least 5 years old
  • Resident of the villages, or temporary visitors, or co-workers or co-travelers of index case
  • Willingness to participate in the study evident by informed consent
Exclusion Criteria
  • Presence of severe clinical illness including severe malaria
  • Non-resident index cases
  • Refusal to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Diagnostic performance of hsRDThsRDTComparing diagnostic power of two diagnostics
Primary Outcome Measures
NameTimeMethod
Prevalence of malaria infections identified by the new hsRDTPCR diagnosis of samples will occur after 10 months of data collection.

Outcomes measured by malaria test positivity rate by cRDT, hsRDT and PCR, respectively

Secondary Outcome Measures
NameTimeMethod
Correlation of detection capability between cRDT and hsRDTPCR results will be analyzed during month 10

Outcomes measured by correlation of test positivity rates

Diagnostic performance characteristics of hsRDT versus cRDT using PCR as gold standard, in the detection of P.falciparum infectionsOutcomes will be analyzed after 10 months of data collection

Outcomes measured between hsRDT and cRDT

Risk factors associated with malaria infection casesOutcome will be measured/analyzed in month 10, after PCR results are released

Outcomes will be measured by relative risk of malaria in association with different risk factors identified

Trial Locations

Locations (1)

University Research Co., LLC (URC)

šŸ‡²šŸ‡²

Yangon, Myanmar

Ā© Copyright 2025. All Rights Reserved by MedPath